Inventor · disambiguated record
Thomas J. Tucker
Also filed as: TUCKER THOMAS · TUCKER THOMAS J · TUCKER THOMAS JOSEPH
38 granted patents·7 pending applications·447 citations·filing 1985–2024
97Inventor score
Files withMERCK & CO INC12MERCK SHARP & DOHME LLC9MERCK SHARP & DOHME7SIRNA THERAPEUTICS INC7RORER PHARMACEUTICAL CORP2
Top patents by PatentIndex Score
45 records- 0197US4666913AHydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their usesRORER INC WILLIAM H·Filed 1985·Granted May 19, 1987·72 cites·21 claims
- 0296US7390798B2Carboxamide spirolactam CGRP receptor antagonistsMERCK & CO INC·Filed 2005·Granted Jun 24, 2008·58 cites·23 claims
- 0395US11484565B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2020·Granted Nov 1, 2022·3 cites·18 claims
- 0493US4866074ANaphtheridinone- and pyridooxazinone-pyridone compounds, cardiotonic compositions including same, and their usesRORER PHARMACEUTICAL CORP·Filed 1988·Granted Sep 12, 1989·42 cites·11 claims
- 0591US5792779APyridinone thrombin inhibitorsMERCK & CO INC·Filed 1997·Granted Aug 11, 1998·59 cites·15 claims
- 0688US11117917B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2019·Granted Sep 14, 2021·2 cites·20 claims
- 0788US10532068B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2018·Granted Jan 14, 2020·3 cites·18 claims
- 0885US11530244B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2019·Granted Dec 20, 2022·6 cites·15 claims
- 0985US7994325B2CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2006·Granted Aug 9, 2011·9 cites·7 claims
- 1085US7265134B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Sep 4, 2007·20 cites·5 claims
- 1184US10221205B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·3 cites·20 claims
- 1284US9655976B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2013·Granted May 23, 2017·6 cites·35 claims
- 1383US11427616B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2019·Granted Aug 30, 2022·3 cites·48 claims
- 1483US7115597B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2003·Granted Oct 3, 2006·19 cites·31 claims
- 1583US5510369APyrrolidine thrombin inhibitorsMERCK & CO INC·Filed 1994·Granted Apr 23, 1996·52 cites·5 claims
- 1682US10010562B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2014·Granted Jul 3, 2018·3 cites·20 claims
- 1779US2025206781A1Pcsk9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1878US8404856B2Non-nucleoside reverse transcriptase inhibitorsTUCKER THOMAS J·Filed 2008·Granted Mar 26, 2013·8 cites·6 claims
- 1977US12304925B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2021·Granted May 20, 2025·0 cites·20 claims
- 2076US10413593B2Co-agonists of the glucagon and GLP-1 receptorsMERCK SHARP & DOHME·Filed 2015·Granted Sep 17, 2019·2 cites·30 claims
- 2176US5798377AThrombin inhibitorsMERCK & CO INC·Filed 1996·Granted Aug 25, 1998·22 cites·17 claims
- 2274US6376496B1Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 2000·Granted Apr 23, 2002·8 cites·33 claims
- 2374US6358956B1Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 2000·Granted Mar 19, 2002·8 cites·22 claims
- 2473US12209145B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 28, 2025·0 cites·29 claims
- 2572US8691580B2Single chemical entities and methods for delivery of oligonucleotidesAARONSON JEFFREY G·Filed 2011·Granted Apr 8, 2014·2 cites·6 claims
- 2671US12178842B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2022·Granted Dec 31, 2024·0 cites·18 claims
- 2769US12012468B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2022·Granted Jun 18, 2024·0 cites·15 claims
- 2868US6355643B1Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 2000·Granted Mar 12, 2002·4 cites·19 claims
- 2967US9840531B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Dec 12, 2017·0 cites·21 claims
- 3062US11932705B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2022·Granted Mar 19, 2024·0 cites·13 claims
- 3160US6127390AInhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 1998·Granted Oct 3, 2000·8 cites·18 claims
- 3260US5629324AThrombin inhibitorsMERCK & CO INC·Filed 1995·Granted May 13, 1997·17 cites·9 claims
- 3358US2017137815A1Novel single chemical entities and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3455US2016074525A1Novel single chemical entities and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3554US2013253168A1Novel single chemical entities and methods for delivery of oligonucleotidesCOLLETTI STEVEN L·Filed 2011·Application pending·0 cites
- 3652US11505575B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 22, 2022·0 cites·23 claims
- 3747US10239957B2Peptide containing conjugates for dual molecular delivery of oligonucleotidesMERCK SHARP & DOHME·Filed 2014·Granted Mar 26, 2019·0 cites·1 claims
- 3845US11306125B2PCSK9 antagonists bicyclo-compoundsMERCK SHARP & DOHME·Filed 2019·Granted Apr 19, 2022·0 cites·15 claims
- 3945US2002137755A1Tyrosine kinase inhibitorsFiled 2001·Application pending·0 cites
- 4044US5714485APiperidine and hexahydropyridazine thrombin inhibitorsMERCK & CO INC·Filed 1995·Granted Feb 3, 1998·7 cites·10 claims
- 4141US7807684B2HIV reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Oct 5, 2010·0 cites·15 claims
- 4241US2004242637A1Tyrosine kinase inhibitorsFiled 2002·Application pending·0 cites
- 4340US5015638ANaphtheridinone- and pyridooxazinone-pyridone compounds, cardiotonic compositions including same, and their usesRHONE POULENC RORER PHARMA·Filed 1989·Granted May 14, 1991·1 cites·23 claims
- 4439US2013203735A1Caprolactam mglur5 receptor modulatorsSISKO JOHN T·Filed 2011·Application pending·0 cites
- 4531US4906629APyridazinone and pyrazolone compounds, cardiotonic compositions including same, and their usesRORER PHARMACEUTICAL CORP·Filed 1988·Granted Mar 6, 1990·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →